Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Inetetamab + Pyrotinib |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Inetetamab | Cipterbin | HER2 (ERBB2) Antibody 76 | Inetetamab is a monoclonal antibody targeting ERBB2 (HER2), which potentially inhibits tumor growth (PMID: 38685972). | |
Pyrotinib | SHR-1258|SHR1258 | EGFR Inhibitor (Pan) 62 HER2 Inhibitor 42 | Pyrotinib is an irreversible dual inhibitor of EGFR and ERBB2 (HER2), which potentially leads to decreased growth of EGFR and/or HER2-positive tumor cells (PMID: 28115222, PMID: 30596880). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|